Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLEXION: Long-term Rebif in Early MS
NCT00813709Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- Dec 2008
- Primary completion
- Aug 2011
- Modality
- Cytokines & Interferons
- Countries
- 24
01
Overview
A Phase 3 trial of interferon beta-1a in multiple sclerosis (MS), clinically isolated syndrome (CIS), sponsored by Merck KGaA. Started Dec 2008; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00813709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813709.